Skip to main content
main-content

Zeitschrift

Japanese Journal of Ophthalmology

The Official International Journal of the Japanese Ophthalmological Society

Japanese Journal of Ophthalmology OnlineFirst articles

19.01.2022 | Clinical Investigation

Multicenter, retrospective, observational study for the Treatment Pattern of systemic corticoSTERoids for relapse of non-infectious uveitis accompanying Vogt-Koyanagi-Harada disease or sarcoidosis

Non-infectious uveitis is associated with several chronic inflammatory conditions and is a leading cause of vision loss [ 1 – 3 ]. Both Vogt-Koyanagi-Harada (VKH) disease and sarcoidosis are multisystemic inflammatory disorders that can lead to …

19.01.2022 | Clinical Investigation

Effectiveness of a photoscreener in identifying undiagnosed unilateral amblyopia at vision screening of 3-year-old children in Japan

Amblyopia is a sight-threatening disorder that can lead to irreversible vision loss if left undetected and untreated in childhood [ 1 ]. As young children have been shown to be most responsive to amblyopia therapy [ 2 ], early detection of …

19.01.2022 | Clinical Investigation

Recent trends in glaucoma surgery: a nationwide database study in Japan, 2011–2019

Glaucoma is the leading cause of blindness in Japan. Regional cohort studies show that the prevalence of glaucoma in Japan is 5% in people older than 40 years [ 1 , 2 ]. As the Japanese population ages, the number of patients with glaucoma is …

19.01.2022 | Clinical Investigation

The prevalence of uncorrected refractive error in Japan: the Locomotive Syndrome and Health Outcome in Aizu Cohort Study

Vision impairment is a leading and largely preventable cause of disability worldwide. Uncorrected refractive error (URE) is the leading cause of vision impairment and the second leading cause of blindness worldwide and affects 108 million people …

19.01.2022 | Laboratory Investigation

Visual cortex damage in a ferret model of ocular hypertension

Glaucoma, the leading cause of irreversible blindness worldwide, is characterized by death of retinal ganglion cells (RGCs) [ 1 , 2 ]. Lowering the intraocular pressure (IOP) is the gold standard for treating glaucoma [ 3 – 8 ]. Additionally …

Aktuelle Ausgaben

Weitere Informationen

Neu im Fachgebiet Augenheilkunde